Drug Discovery Technology Review: Emerging Tools and Modalities in 2022Q2/Q3

We did a deep dive into the pharmaceutical industry’s 2022Q2/Q3 news, and there’s a ton of exciting updates to share. In this review, we highlight some emerging companies, technologies, and drug discovery modalities we thought drug hunters would find interesting, including:

• New strategies for covalent protein modification

• Different methods for screening drug candidates and targets

• Interesting new approaches with large molecules

• Recent updates in radiopharmaceuticals